Cardiovascular disease (prevalent) · Adults (general population)
Meta-analysis of observational studies (higher vs lower 25(OH)D) for Cardiovascular disease (prevalent): OR 0.67 (95% CI 0.55 to 0.82), statistically significant. Umbrella review outcome-level evidence grade: Suggestive.
1 finding from 1 review
Ovarian cancer · Adults (general population)
Meta-analysis of observational studies (higher vs lower 25(OH)D) for Ovarian cancer: OR 0.83 (95% CI 0.63 to 1.09), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.
1 finding from 1 review
Stroke · Adults (general population)
Meta-analysis of observational studies (higher vs lower 25(OH)D) for Stroke: RR 0.61 (95% CI 0.50 to 0.75), statistically significant. Umbrella review outcome-level evidence grade: Suggestive.
1 finding from 1 review
Colon cancer · Adults (general population)
Meta-analysis of observational studies (higher vs lower 25(OH)D) for Colon cancer: OR 0.78 (95% CI 0.56 to 1.07), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.
1 finding from 1 review
Cholesterol mg/dL · Adults (general population)
Meta-analysis of randomised trials of vitamin D supplementation for Total cholesterol: WMD 1.52 (95% CI -1.42 to 4.46), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.
1 finding from 1 review
WMD 1.52 [-1.42, 4.46]
11 studies
GRADE not reported
Colorectal cancer · Adults (general population)
Meta-analysis of observational studies (higher vs lower 25(OH)D) for Colorectal cancer: RR 0.70 (95% CI 0.58 to 0.84), statistically significant. Umbrella review outcome-level evidence grade: Suggestive.
1 finding from 1 review
Mortality (all cause) · Adults (general population)
Meta-analysis of randomised trials of vitamin D supplementation for Mortality (all cause) (Vitamin D2, general population): RR 1.04 (95% CI 0.97 to 1.11), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.
2 findings from 1 review
CVD · Adults (general population)
Meta-analysis of observational studies (higher vs lower 25(OH)D) for Cardiovascular disease: RR 0.66 (95% CI 0.57 to 0.77), statistically significant. Umbrella review outcome-level evidence grade: Suggestive.
1 finding from 1 review
Depression · Adults (general population)
Meta-analysis of observational studies (higher vs lower 25(OH)D) for Depression (Cohort studies): HR 0.44 (95% CI 0.27 to 0.72), statistically significant. Umbrella review outcome-level evidence grade: Suggestive.
2 findings from 1 review
Serum fasting triglyceride (TG, mmol/L) · Adults (general population)
Meta-analysis of randomised trials of vitamin D supplementation for Triglycerides: WMD -1.92 (95% CI -7.72 to 3.88), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.
1 finding from 1 review
WMD -1.92 [-7.72, 3.88]
8 studies
GRADE not reported
Breast cancer · Adults (general population)
Meta-analysis of observational studies (higher vs lower 1,25(OH)2D) for Breast cancer: OR 0.99 (95% CI 0.68 to 1.44), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.
1 finding from 1 review
Ischaemic stroke · Adults (general population)
Meta-analysis of observational studies (higher vs lower 25(OH)D) for Ischaemic stroke (Hazard ratio (cohort studies)): HR 0.66 (95% CI 0.55 to 0.80), statistically significant. Umbrella review outcome-level evidence grade: Suggestive.
2 findings from 1 review
High density lipoprotein · Adults (general population)
Meta-analysis of randomised trials of vitamin D supplementation for High density lipoprotein: WMD -0.14 (95% CI -0.99 to 0.71), not statistically significant. Umbrella review outcome-level evidence grade: Substantial effect unlikely.
1 finding from 1 review
WMD -0.14 [-0.99, 0.71]
8 studies
GRADE not reported
Colon cancer · Adults (general population)
Meta-analysis of observational studies (higher vs lower 1,25(OH)2D) for Colon cancer: OR 0.88 (95% CI 0.57 to 1.35), not statistically significant. Umbrella review outcome-level evidence grade: No conclusion.
1 finding from 1 review
OR 0.88 [0.57, 1.35]
4 studies
GRADE not reported
Aggressive prostate cancer · Adults (general population)
Meta-analysis of observational studies (higher vs lower 1,25(OH)2D) for Aggressive prostate cancer: OR 0.75 (95% CI 0.48 to 1.17), not statistically significant. Umbrella review outcome-level evidence grade: Substantial effect unlikely.
1 finding from 1 review
Prostate cancer · Adults (general population)
Meta-analysis of observational studies (higher vs lower 1,25(OH)2D) for Prostate cancer: OR 0.99 (95% CI 0.87 to 1.14), not statistically significant. Umbrella review outcome-level evidence grade: Substantial effect unlikely.
1 finding from 1 review
Kidney cancer · Adults (general population)
Meta-analysis of observational studies (higher vs lower 25(OH)D) for Kidney cancer: OR 1.01 (95% CI 0.65 to 1.58), not statistically significant. Umbrella review outcome-level evidence grade: Substantial effect unlikely.
1 finding from 1 review
Serum low‐density lipoprotein (LDL, mmol/L) · Adults (general population)
Meta-analysis of randomised trials of vitamin D supplementation for Low density lipoprotein: WMD 3.23 (95% CI 0.55 to 5.9), statistically significant. Umbrella review outcome-level evidence grade: Suggestive.
1 finding from 1 review
WMD 3.23 [0.55, 5.9]
7 studies
GRADE not reported
CVD · Adults (general population)
Meta-analysis of randomised trials of vitamin D supplementation for Cardiovascular disease: RR 0.95 (95% CI 0.86 to 1.05), not statistically significant. Umbrella review outcome-level evidence grade: Suggestive.
1 finding from 1 review
RR 0.95 [0.86, 1.05]
2 studies
GRADE not reported
Body‐mass index (BMI) · Adults (general population)
Meta-analysis of observational studies (higher vs lower 25(OH)D) for Body mass index: Z score -0.15 (95% CI -0.19 to -0.11), statistically significant. Umbrella review outcome-level evidence grade: Suggestive.
1 finding from 1 review